These interactions include, but are not limited to, mRNAs of definite ALS genes TARDBP, FUS (FXR2), and VCP (all three FXPs), as well as the clinical modifier ATXN2 (FXR2; classification of ALS genes according to [90, 91]). The gene discussed is VCP; the disease is amyotrophic lateral sclerosis.